BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5536480)

  • 1. A feast for nephrophiles.
    Vaisrub S
    JAMA; 1970 Dec; 214(11):2048-9. PubMed ID: 5536480
    [No Abstract]   [Full Text] [Related]  

  • 2. New method for measurement of guanidinosuccinic acid in serum and urine.
    Gróf J; Tankó A; Menyhárt J
    Clin Chem; 1974 May; 20(5):574-5. PubMed ID: 4826951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic renal failure and guanidino compounds].
    Kinoshita T
    Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte transketolase activity and guanidino compounds in hemodialysis patients.
    Pietrzak I; Baczyk K
    Kidney Int Suppl; 2001 Feb; 78():S97-101. PubMed ID: 11168992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bicarbonate output in the duodenal juice and various biochemical blood indicators in dialyzed patients].
    Grzegorzewska A; Rajewska J; Szmeja K; Pietrzak I; Czekalski S
    Przegl Lek; 1986; 43(7):512-6. PubMed ID: 3775063
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential removal of guanidinosuccinic acid and creatine by hemodialysis and continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Billiouw JM; Becaus I; Lornoy W
    Nephron; 1991; 57(3):369-70. PubMed ID: 2017282
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 8. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
    Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
    J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
    [No Abstract]   [Full Text] [Related]  

  • 9. The ultimate salt war? Uraemic toxins are all that count in dialysis patients.
    Vanholder R
    Nephrol Dial Transplant; 2012 Jan; 27(1):62-6. PubMed ID: 22287703
    [No Abstract]   [Full Text] [Related]  

  • 10. Semiautomated method for measurement of guanidinosuccinic acid in serum.
    Kamoun PP; Pleau JM; Man NK
    Clin Chem; 1972 Apr; 18(4):355-7. PubMed ID: 5012258
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guanidinosuccinic acid and uremia. 1. Clinical studies].
    Dobbelstein H; Edel HH; Schmidt M; Schubert G; Weinzierl M
    Klin Wochenschr; 1971 Mar; 49(6):348-57. PubMed ID: 4929965
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum middle molecules in uremia.
    Buzio C; Manari A; Calderini C; Montagna G; Migone L
    Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract]   [Full Text] [Related]  

  • 13. Removal of high-molecular-weight toxins.
    Hörl WH
    Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
    [No Abstract]   [Full Text] [Related]  

  • 14. Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding.
    Horowitz HI; Stein IM; Cohen BD; White JG
    Am J Med; 1970 Sep; 49(3):336-45. PubMed ID: 5455565
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of guanidinosuccinic acid on in vitro carbohydrate metabolism.
    Davidson MB
    Experientia; 1970 Nov; 26(11):1206-7. PubMed ID: 5485279
    [No Abstract]   [Full Text] [Related]  

  • 16. Separation, isolation, and identification of middle molecules.
    Bergström J; Fürst P; Zimmerman L
    Artif Organs; 1981; 4 Suppl():5-7. PubMed ID: 7295096
    [No Abstract]   [Full Text] [Related]  

  • 17. Removal of guanidinosuccinic acid by hemodialysis.
    Perez G; Abraira C; Rey A; Horn M
    Nephron; 1977; 19(4):214-9. PubMed ID: 917168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for combined hemoperfusion/hemodialysis in uremia.
    Winchester JF; Ronco C; Brady JA; Brendolan A; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Clemmer J; Polaschegg HD; Muller TE; La Greca G; Levin NW
    Contrib Nephrol; 2001; (133):174-9. PubMed ID: 11477750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 20. A purification method by uncoated charcoal.
    Cerulli N; Politi L; D'Angelo AR; Scandurra R
    Adv Exp Med Biol; 1987; 223():193-6. PubMed ID: 3447435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.